Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications

Previous research has demonstrated aberrations in the levels of inflammatory cytokines in patients with schizophrenia (SCZ), but most of the respective studies have tested a narrow set of inflammatory cytokines. Here, we aimed to analyze broad immune profiles in the peripheral blood of the first-epi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lei Chen, Wen-Hui Zheng, Yang Du, Xue-Song Li, Yun Yu, Hua Wang, Yong Cheng
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/3f7b67d32b6b492a871f13e3a66b0798
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3f7b67d32b6b492a871f13e3a66b0798
record_format dspace
spelling oai:doaj.org-article:3f7b67d32b6b492a871f13e3a66b07982021-11-30T18:13:20ZAltered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications2296-858X10.3389/fmed.2021.757655https://doaj.org/article/3f7b67d32b6b492a871f13e3a66b07982021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.757655/fullhttps://doaj.org/toc/2296-858XPrevious research has demonstrated aberrations in the levels of inflammatory cytokines in patients with schizophrenia (SCZ), but most of the respective studies have tested a narrow set of inflammatory cytokines. Here, we aimed to analyze broad immune profiles in the peripheral blood of the first-episode drug-free (FEDF) patients with SCZ at baseline and after an 8-week treatment with atypical antipsychotics. Serum samples from 24 FEDF patients with SCZ and 25 healthy control (HC) subjects were tested using Luminex multiplex analysis for 30 cytokines, chemokines, and growth factors. Multiple comparison tests demonstrated that interleukin-2 (IL-2), IL-4, interferon-gamma (IFN-γ), monokine induced by IFN-γ, and granulocyte colony-stimulating factor (G-CSF) levels were significantly increased, whereas those of the epidermal growth factor were significantly decreased in the FEDF patients with SCZ. Moreover, the levels of the 6 dysregulated cytokines as well as those of 12 additional soluble factors in FEDF patients with SCZ were significantly decreased after 8 weeks of antipsychotic treatment. Furthermore, the transcription of G-CSF and IFN-γ was significantly increased in FEDF patients with SCZ when compared with controls, and G-CSF and IFN-γ mRNA levels were highly correlated with their respective protein concentrations. Receiver operating characteristic curves showed that G-CSF and IFN-γ had good performance in differentiating between FEDF patients with SCZ and HC subjects. Taken together, our data revealed that FEDF patients with SCZ were accompanied by a unique pattern of immune profile, and antipsychotic medications seemed to suppress the immune function in these patients, which could be used to develop novel targets for the diagnosis and treatment of SCZ.Lei ChenLei ChenWen-Hui ZhengYang DuXue-Song LiYun YuHua WangYong ChengYong ChengFrontiers Media S.A.articlecytokineschizophreniafirst-episodedrug-freeantipsychoticsbiomarkerMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic cytokine
schizophrenia
first-episode
drug-free
antipsychotics
biomarker
Medicine (General)
R5-920
spellingShingle cytokine
schizophrenia
first-episode
drug-free
antipsychotics
biomarker
Medicine (General)
R5-920
Lei Chen
Lei Chen
Wen-Hui Zheng
Yang Du
Xue-Song Li
Yun Yu
Hua Wang
Yong Cheng
Yong Cheng
Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
description Previous research has demonstrated aberrations in the levels of inflammatory cytokines in patients with schizophrenia (SCZ), but most of the respective studies have tested a narrow set of inflammatory cytokines. Here, we aimed to analyze broad immune profiles in the peripheral blood of the first-episode drug-free (FEDF) patients with SCZ at baseline and after an 8-week treatment with atypical antipsychotics. Serum samples from 24 FEDF patients with SCZ and 25 healthy control (HC) subjects were tested using Luminex multiplex analysis for 30 cytokines, chemokines, and growth factors. Multiple comparison tests demonstrated that interleukin-2 (IL-2), IL-4, interferon-gamma (IFN-γ), monokine induced by IFN-γ, and granulocyte colony-stimulating factor (G-CSF) levels were significantly increased, whereas those of the epidermal growth factor were significantly decreased in the FEDF patients with SCZ. Moreover, the levels of the 6 dysregulated cytokines as well as those of 12 additional soluble factors in FEDF patients with SCZ were significantly decreased after 8 weeks of antipsychotic treatment. Furthermore, the transcription of G-CSF and IFN-γ was significantly increased in FEDF patients with SCZ when compared with controls, and G-CSF and IFN-γ mRNA levels were highly correlated with their respective protein concentrations. Receiver operating characteristic curves showed that G-CSF and IFN-γ had good performance in differentiating between FEDF patients with SCZ and HC subjects. Taken together, our data revealed that FEDF patients with SCZ were accompanied by a unique pattern of immune profile, and antipsychotic medications seemed to suppress the immune function in these patients, which could be used to develop novel targets for the diagnosis and treatment of SCZ.
format article
author Lei Chen
Lei Chen
Wen-Hui Zheng
Yang Du
Xue-Song Li
Yun Yu
Hua Wang
Yong Cheng
Yong Cheng
author_facet Lei Chen
Lei Chen
Wen-Hui Zheng
Yang Du
Xue-Song Li
Yun Yu
Hua Wang
Yong Cheng
Yong Cheng
author_sort Lei Chen
title Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_short Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_full Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_fullStr Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_full_unstemmed Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
title_sort altered peripheral immune profiles in first-episode, drug-free patients with schizophrenia: response to antipsychotic medications
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/3f7b67d32b6b492a871f13e3a66b0798
work_keys_str_mv AT leichen alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT leichen alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT wenhuizheng alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT yangdu alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT xuesongli alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT yunyu alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT huawang alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT yongcheng alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
AT yongcheng alteredperipheralimmuneprofilesinfirstepisodedrugfreepatientswithschizophreniaresponsetoantipsychoticmedications
_version_ 1718406373610356736